Primary Immunodeficiency Diseases: Clinical Trials

3 trials for Primary Immunodeficiency Diseases, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 enrolling by invitation. 3 Phase 2, 2 Phase 1, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 23Enrolling by invitation 3
Phase 12Enrolling by invitation 2
Phase 31Enrolling by invitation 1

Follow Primary Immunodeficiency Diseases: new trials by email Literature Review of Primary Immunodeficiency Diseases trials Research Report on Primary Immunodeficiency Diseases

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Base-Edited Hematopoietic Stem/Progenitor Cell X-Linked Severe Combined Immunodeficiency Gene Therapy
Plerixafor, Filgrastim, Palifermin - X-linked Severe Combined Immunodeficiency, X-SCID
Phase 1 / Phase 2Enrolling by invitationNational Institute of Allergy and Infectious Diseases (NIAID)182025-05-092026-10-13
Extension Study of Oral PHA-022121 for Acute Treatment of Angioedema Attacks in Patients With Hereditary Angioedema
deucrictibant - Hereditary Angioedema, Hereditary Angioedema Type I
Phase 2 / Phase 3Enrolling by invitationPharvaris Netherlands B.V.1502022-12-282026-07-21
Sequential Cadaveric Lung and Bone Marrow Transplant for Immune Deficiency Diseases
CD3/CD19 negative allogeneic hematopoietic stem cells - Severe Combined Immunodeficiency (SCID), Immunodeficiency With Predominant T-cell Defect, Unspecified
Phase 1 / Phase 2Enrolling by invitationPaul Szabolcs162013-06-202025-12-15

Narrower conditions

Angioedemas, Hereditary (1)  ·  Common Variable Immunodeficiency (1)  ·  Granulomatous Disease, Chronic (1)  ·  Hereditary Angioedema Type III (1)  ·  Hereditary Angioedema Types I and II (1)  ·  Job Syndrome (1)  ·  Neutropenia, severe chronic (1)  ·  Severe Combined Immunodeficiency (1)  ·  Wiskott-Aldrich Syndrome (1)  ·  X-Linked Combined Immunodeficiency Diseases (1)

Broader conditions

Congenital, Hereditary, and Neonatal Diseases and Abnormalities (3)  ·  Genetic Diseases, Inborn (3)  ·  Immune System Diseases (3)  ·  Immunologic Deficiency Syndromes (3)  ·  Genetic Diseases, X-Linked (2)  ·  Infant, Newborn, Diseases (2)  ·  Angioedema (1)  ·  Blood Coagulation Disorders (1)  ·  Blood Coagulation Disorders, Inherited (1)  ·  Cardiovascular Diseases (1)  ·  Chronic Disease (1)  ·  Cytopenia (1)  ·  DNA Repair-Deficiency Disorders (1)  ·  Disease Attributes (1)

Interventions

Busulfan (1)  ·  Fibroblast Growth Factor 7 (1)  ·  Filgrastim (1)  ·  plerixafor (1)

Sponsors

National Institute of Allergy and Infectious Diseases (NIAID) (1)  ·  Paul Szabolcs (1)  ·  Pharvaris Netherlands B.V. (1)

Countries

United States (3)  ·  Argentina (1)  ·  Australia (1)  ·  Austria (1)  ·  Brazil (1)  ·  Bulgaria (1)  ·  Canada (1)  ·  Czechia (1)  ·  France (1)  ·  Germany (1)  ·  Hong Kong (1)  ·  Hungary (1)  ·  Israel (1)  ·  Italy (1)  ·  Japan (1)

Top investigators

Paul Szabolcs, MD (1)  ·  Suk S De Ravin, M.D. (1)

NIH funding

2023 (1)